Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.14p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 604,698
  • Market Cap: £8.91m
  • RiskGrade: 328

Regulatory News

Directorate Change 11-Aug-2023 12:04 RNS
Result of AGM 30-Jun-2023 13:12 RNS
Lupuzor Update 19-Jun-2023 07:00 RNS
IMM RNS Posting of RA and Notice of AGM 30 June 23 06-Jun-2023 07:00 RNS
Positive Pre-IND meeting with FDA 18-May-2023 07:00 RNS
Final Results 11-May-2023 07:00 RNS
Holding(s) in Company 10-May-2023 13:56 RNS
Lupozor Update - FDA confirms Type-C meeting date 19-Apr-2023 07:00 RNS
CIDP P140 Clinical Program Update 12-Apr-2023 07:00 RNS
Lupuzor™ Update 27-Mar-2023 07:00 RNS
Price Monitoring Extension 09-Mar-2023 16:35 RNS
Collaboration with Orano on ImmuPharma Peptide 06-Mar-2023 07:00 RNS
Lupuzor™ Update 06-Feb-2023 07:00 RNS
TR-1: Notification of major holdings 27-Jan-2023 16:25 RNS
TR-1: Notification of major holdings 04-Jan-2023 17:26 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.14p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.42
52 Week Low 0.85
Volume 604,698
Shares Issued 416.44m
Market Cap £8.91m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.4% below the market average64.4% below the market average64.4% below the market average64.4% below the market average64.4% below the market average
5.66% below the sector average5.66% below the sector average5.66% below the sector average5.66% below the sector average5.66% below the sector average
Price Trend
25.07% below the market average25.07% below the market average25.07% below the market average25.07% below the market average25.07% below the market average
40.35% above the sector average40.35% above the sector average40.35% above the sector average40.35% above the sector average40.35% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
15:55 20,000 @ 2.14p
15:13 60,201 @ 2.14p
13:57 25,000 @ 2.14p
13:54 50,000 @ 2.14p
12:33 603 @ 2.20p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page